Correlation Between CSL and Jazz Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both CSL and Jazz Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CSL and Jazz Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between CSL LTD SPONADR and Jazz Pharmaceuticals plc, you can compare the effects of market volatilities on CSL and Jazz Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CSL with a short position of Jazz Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of CSL and Jazz Pharmaceuticals.
Diversification Opportunities for CSL and Jazz Pharmaceuticals
-0.6 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between CSL and Jazz is -0.6. Overlapping area represents the amount of risk that can be diversified away by holding CSL LTD SPONADR and Jazz Pharmaceuticals plc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Jazz Pharmaceuticals plc and CSL is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CSL LTD SPONADR are associated (or correlated) with Jazz Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Jazz Pharmaceuticals plc has no effect on the direction of CSL i.e., CSL and Jazz Pharmaceuticals go up and down completely randomly.
Pair Corralation between CSL and Jazz Pharmaceuticals
Assuming the 90 days trading horizon CSL LTD SPONADR is expected to generate 0.8 times more return on investment than Jazz Pharmaceuticals. However, CSL LTD SPONADR is 1.25 times less risky than Jazz Pharmaceuticals. It trades about 0.04 of its potential returns per unit of risk. Jazz Pharmaceuticals plc is currently generating about 0.01 per unit of risk. If you would invest 7,239 in CSL LTD SPONADR on September 26, 2024 and sell it today you would earn a total of 1,011 from holding CSL LTD SPONADR or generate 13.97% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
CSL LTD SPONADR vs. Jazz Pharmaceuticals plc
Performance |
| Timeline |
| CSL LTD SPONADR |
| Jazz Pharmaceuticals plc |
CSL and Jazz Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with CSL and Jazz Pharmaceuticals
The main advantage of trading using opposite CSL and Jazz Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CSL position performs unexpectedly, Jazz Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Jazz Pharmaceuticals will offset losses from the drop in Jazz Pharmaceuticals' long position.| CSL vs. IMAGIN MEDICAL INC | CSL vs. Merit Medical Systems | CSL vs. Perdoceo Education | CSL vs. Sims Metal Management |
| Jazz Pharmaceuticals vs. Novo Nordisk AS | Jazz Pharmaceuticals vs. Mercedes Benz Group AG | Jazz Pharmaceuticals vs. Vertex Pharmaceuticals Incorporated | Jazz Pharmaceuticals vs. Moderna |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Complementary Tools
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |